- Home
- OXSQ vs SCPH Comparison
OXSQ vs SCPH Comparison
Compare OXSQ & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXSQ
- SCPH
- Stock Information
- Founded
- OXSQ 2003
- SCPH 2013
- Country
- OXSQ United States
- SCPH United States
- Employees
- OXSQ N/A
- SCPH N/A
- Industry
- OXSQ Blank Checks
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- OXSQ Finance
- SCPH Health Care
- Exchange
- OXSQ Nasdaq
- SCPH Nasdaq
- Market Cap
- OXSQ 190.1M
- SCPH 173.6M
- IPO Year
- OXSQ N/A
- SCPH 2017
- Fundamental
- Price
- OXSQ $2.60
- SCPH $2.63
- Analyst Decision
- OXSQ
- SCPH Strong Buy
- Analyst Count
- OXSQ 0
- SCPH 3
- Target Price
- OXSQ N/A
- SCPH $14.00
- AVG Volume (30 Days)
- OXSQ 446.4K
- SCPH 624.1K
- Earning Date
- OXSQ 05-01-2025
- SCPH 03-19-2025
- Dividend Yield
- OXSQ 16.09%
- SCPH N/A
- EPS Growth
- OXSQ N/A
- SCPH N/A
- EPS
- OXSQ 0.09
- SCPH N/A
- Revenue
- OXSQ $42,683,205.00
- SCPH $36,332,000.00
- Revenue This Year
- OXSQ $8.73
- SCPH $134.20
- Revenue Next Year
- OXSQ N/A
- SCPH $99.40
- P/E Ratio
- OXSQ $28.17
- SCPH N/A
- Revenue Growth
- OXSQ N/A
- SCPH 167.28
- 52 Week Low
- OXSQ $2.40
- SCPH $2.50
- 52 Week High
- OXSQ $3.29
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- OXSQ 38.23
- SCPH 30.22
- Support Level
- OXSQ $2.56
- SCPH $2.87
- Resistance Level
- OXSQ $2.61
- SCPH $3.08
- Average True Range (ATR)
- OXSQ 0.05
- SCPH 0.19
- MACD
- OXSQ -0.01
- SCPH -0.02
- Stochastic Oscillator
- OXSQ 38.64
- SCPH 18.84
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing, and Diversified Insurance.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.